The European Congress of Radiology (ECR) 2026 will spotlight the latest research from the RadioVal Project.
Titled “Advancing trustworthy AI for breast cancer treatment planning: insights from the RadioVal project,” this session will explore how artificial intelligence is shaping the future of breast cancer imaging and clinical decision-making through transparency, fairness, and robust validation.
Tuesday, March 4, 2026 | 13:00 – 14:30 CET
Attendees will:
Discover how the FUTURE-AI (Fairness, Universality, Traceability, Usability, Robustness, and Explainability) guidelines support the development of trustworthy AI tools for breast cancer imaging.
Learn about advancements in AI traceability and explainability that enhance clinical decision support.
Explore current validation strategies ensuring reliability and clinical effectiveness of AI systems in breast cancer diagnosis.
Don’t miss this opportunity to hear from the RadioVal team and learn how international collaboration is advancing trustworthy AI in oncology.